Available in:Injectable Pen
Dosage:0.25mg, 0.5mg, 1mg
Manufacturer:Novo Nordisk
Available in:Injectable
Dosage:100U/ML
Manufacturer:Sanofi-Aventis
As Canada's leading online pharmacy, we make sure you always have your meds on time. Use our app and website to fill prescriptions, order refills, and consult with our pharmacists. Take control of your health from home or on the go!
We won't bore you with the details, but Health Canada requires you to sign in.
By proceeding you agree to our Terms of Use & Privacy Policy
Each 1 mL of clear, colourless solution contains 1.34 mg of Ozempic (Semaglutide). Nonmedicianl ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injections.
There are 2 forms of the pre-filled, multi-dose, disposable pen. One pen delivers doses of 0.25 mg and 0.5 mg Ozempic (Semaglutide), while the other pen delivers 1 mg doses only.
Each pen contains 2 mg of Ozempic (Semaglutide).
Your required dose of insulin depends on how much natural insulin your pancreas is producing and how well your body is able to use the insulin. Your doctor or diabetes educator will determine the appropriate dose for you according to various lifestyle factors and the blood glucose values obtained while monitoring your blood glucose.
Your dose of insulin should be injected subcutaneously (under the skin) exactly as instructed by your doctor or diabetes educator. Do not inject insulin glargine into the vein and do not use insulin glargine in insulin infusion pumps. The dose of insulin is measured in international units (IU). Each 1 mL of insulin contains 100 IU. Insulin glargine is injected under the skin once daily. In addition to insulin glargine, doses of a fast-acting insulin are usually used to control the impact of food intake on blood sugar levels during the day. There are many variations of insulin dosing.
Insulin glargine should be clear and colourless. Do not use the insulin if you notice anything unusual in the appearance of the solution, such as cloudiness, discoloration, or clumping. It is not necessary to shake or rotate the vial before use. It should not be mixed with other insulins.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are using the medication without consulting your doctor.
It is very important to use Lantus (Insulin-glargine-long-acting) exactly as prescribed by your doctor. The timing of insulin with respect to your meals is crucial to keeping blood sugar under control and preventing unwanted side effects.
Keep unopened bottles of insulin in the refrigerator until needed. They may be used until the expiry date on the label. Never allow insulin to freeze. Insulin that is currently in use may be kept at room temperature for no more than 28 days and then discarded. Do not expose insulin to extremely hot temperatures or to sunlight. Keep insulin out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Ozempic (Semaglutide). If you are concerned about side effects, discuss the risks and benefits of Ozempic (Semaglutide) with your doctor.
The following side effects have been reported by at least 1% of people taking Ozempic (Semaglutide). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Ozempic (Semaglutide).
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent. The side effects listed below are not experienced by everyone who takes Lantus (Insulin-glargine-long-acting). If you are concerned about side effects, discuss the risks and benefits of Lantus (Insulin-glargine-long-acting) with your doctor.
The following side effects have been reported by at least 1% of people taking Lantus (Insulin-glargine-long-acting). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not check with your doctor or seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Lantus (Insulin-glargine-long-acting).
Each 1 mL of clear, colourless solution contains 1.34 mg of Ozempic (Semaglutide). Nonmedicianl ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injections.
There are 2 forms of the pre-filled, multi-dose, disposable pen. One pen delivers doses of 0.25 mg and 0.5 mg Ozempic (Semaglutide), while the other pen delivers 1 mg doses only.
Each pen contains 2 mg of Ozempic (Semaglutide).
Vial
Each mL of sterile solution contains 100 units of insulin glargine. Nonmedicinal ingredients: glycerol, m-cresol, polysorbate 20 (10 mL vial only), water for injection, and zinc. Hydrochloric acid and sodium hydroxide may have been added to adjust for pH.
Cartridge
Each mL of sterile solution contains 100 units of insulin glargine. Nonmedicinal ingredients: glycerol, m-cresol, polysorbate 20 (10 mL vial only), water for injection, and zinc. Hydrochloric acid and sodium hydroxide may have been added to adjust for pH.
SoloSTAR disposable pen
Each mL of sterile solution contains 100 units of insulin glargine. Nonmedicinal ingredients: glycerol, m-cresol, polysorbate 20 (10 mL vial only), water for injection, and zinc. Hydrochloric acid and sodium hydroxide may have been added to adjust for pH.
Do not take Ozempic (Semaglutide) if you:
Do not use insulin glargine if you:
There may be an interaction between Ozempic (Semaglutide) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Ozempic (Semaglutide). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
All material copyright MediResource Inc. 1996-2021. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Source: www.medbroadcast.com/drug/getdrug/Ozempic
There may be an interaction between insulin glargine and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Lantus (Insulin-glargine-long-acting). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications that you are taking. Also tell them about any supplements you take. Since caffeine, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Ozempic (Semaglutide).
Diabetes identification: It is important to either wear a bracelet (or necklace) or carry a card indicating you have diabetes and are taking medication to manage your blood glucose levels.
Heart problems: Ozempic (Semaglutide) may increase heart rate and may affect how electrical impulses travel through the heart muscle. If you have heart disease or an abnormal heart rhythm (e.g., heart block or fast heart rate), discuss with your doctor how Ozempic (Semaglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Ozempic (Semaglutide), and whether any special monitoring is needed.
Kidney function: Ozempic (Semaglutide) may cause decreased kidney function, kidney failure or worsening chronic kidney failure. If you have reduced kidney function or Kidney Disease, discuss with your doctor how Ozempic (Semaglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Ozempic (Semaglutide), and whether any special monitoring is needed.
Low blood glucose (hypoglycemia): People who use Ozempic (Semaglutide) and are also taking a sulfonylurea (e.g., glyburide, Gliclazide) or insulin to control high blood sugar are more at risk of experiencing hypoglycemia (low blood sugar). If you experience symptoms of hypoglycemia such as a cold sweat, nervousness or shakiness, fast heartbeat, headache, hunger, confusion, lightheadedness, weakness, and numbness or tingling of the tongue or lips, contact your doctor. Your doctor may need to adjust the dose of your medication(s).
Pancreatitis (inflammation of the pancreas): Ozempic (Semaglutide) can cause pancreatitis. If you experience symptoms of pancreatitis such as severe and persistent abdominal pain that may move to the back with or without vomiting, contact your doctor immediately. If you have previously had pancreatitis, discuss with your doctor how Ozempic (Semaglutide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Ozempic (Semaglutide), and whether any special monitoring is needed.
Risk of thyroid cancer: In rare cases, people have developed thyroid cancer while using medications similar to Ozempic (Semaglutide). People with a personal or family history of thyroid cancer or people who have multiple endocrine neoplasia syndrome type 2 (a disease where people have tumours in more than one gland in their body) should not use Ozempic (Semaglutide). If you develop difficulty swallowing or breathing, hoarseness or notice a mass developing in your neck, contact your doctor as soon as possible.
Pregnancy: Ozempic (Semaglutide) should not be used during pregnancy. If you become pregnant while using Ozempic (Semaglutide), contact your doctor immediately.
Breast-feeding: It is not known if Ozempic (Semaglutide) passes into breast milk. If you are a breast-feeding mother and are taking Ozempic (Semaglutide), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Ozempic (Semaglutide) have not been established for children.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Lantus (Insulin-glargine-long-acting).
Allergic reactions: If you notice signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, wheezing, or itchy skin rash), stop using the medication and seek immediate medical attention.
Appearance of insulin: The contents of the vial of insulin glargine should be clear and colourless. Do not use Lantus (Insulin-glargine-long-acting) if you notice anything unusual about its appearance, such as cloudiness, discoloration, or clumping.
Blood glucose monitoring: It is important for anyone using insulin to monitor their blood glucose levels regularly, as recommended by their doctor or diabetes educator. It is especially important to test blood glucose more often when your insulin dose or schedule changes, or when you are ill or under stress. If blood tests consistently show high or low blood glucose levels, contact your doctor or diabetes educator.
Changes at injection site: Fatty tissue under the skin at the injection site may shrink or thicken if you inject yourself too often at the same site. To help avoid this effect, change the site with each injection. Talk to your doctor or diabetes educator if you notice your skin pitting or thickening at the injection site.
Changes in insulin requirements: Many things can affect blood glucose levels and insulin requirements. These include:
It is important your doctor know your current health situation and any changes that may affect the amount of insulin you need. Blood glucose should be monitored regularly as recommended by your doctor or diabetes educator.
Diabetes identification: It is important to either wear a bracelet (or necklace) or carry a card indicating you have diabetes and are taking insulin.
Family and friends: Educate your family and friends about the signs and symptoms of hypoglycemia (low blood glucose). Keep a Glucagon kit available and instruct them on its proper use in case you experience severe low blood glucose and you lose consciousness.
High blood glucose (hyperglycemia): Hyperglycemia may occur if your insulin dose is too low or you miss a dose of insulin. Symptoms of hyperglycemia generally build up over hours or days. If you experience symptoms of hyperglycemia, such as increased need to urinate, nausea, vomiting, drowsiness, Dry Mouth, flushed dry skin, loss of appetite, and a fruity odour to your breath, contact your doctor or diabetes educator immediately.
If hyperglycemia is allowed to continue, a condition known as diabetic ketoacidosis may occur. In this condition, your body starts to use body fat as fuel, eventually leading to a large concentration of acid in the blood stream. This can result in unconsciousness, coma, or death. To prevent this from occurring, you may need to have your insulin dose adjusted.
Kidney function: Kidney Disease or reduced kidney function may change the amount of insulin needed by the body. If you have kidney problems, discuss with your doctor how Lantus (Insulin-glargine-long-acting) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Lantus (Insulin-glargine-long-acting), and whether any special monitoring is needed. Your doctor may want to test your kidney function regularly with blood tests while you are taking Lantus (Insulin-glargine-long-acting).
Liver function: Liver disease or reduced liver function may change the amount of insulin needed by the body. If you have liver problems, discuss with your doctor how Lantus (Insulin-glargine-long-acting) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Lantus (Insulin-glargine-long-acting), and whether any special monitoring is needed. Your doctor may want to test your liver function regularly with blood tests while you are taking Lantus (Insulin-glargine-long-acting).
Low blood glucose (hypoglycemia): Hypoglycemia may occur if too much insulin is used, if meals are missed, or if you exercise more than usual. Symptoms of mild to moderate hypoglycemia may occur suddenly and can include cold sweat, nervousness or shakiness, fast heartbeat, headache, hunger, confusion, lightheadedness, weakness, and numbness or tingling (tongue, lips, or fingers). Mild to moderate hypoglycemia may be treated by eating foods or drinks that contain sugar. People taking insulin should always carry a quick source of sugar, such as hard candies, glucose tablets, juice, or regular soft drinks (not diet soft drinks).
Signs of severe hypoglycemia can include disorientation, loss of consciousness, and seizures. People who are unable to take sugar by mouth or who are unconscious may require an injection of glucagon or treatment with intravenous (into the vein) glucose.
Pregnancy: It is essential to maintain good blood glucose control throughout pregnancy. Insulin requirements usually decrease during the first trimester and increase during the second and third trimesters. Therefore, contact your doctor if you are pregnant or are thinking about pregnancy.
Breast-feeding: It is not known if insulin glargine passes into breast milk. If you are a breast-feeding mother and are using Lantus (Insulin-glargine-long-acting), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding. Breast-feeding mothers may require adjustments in insulin dose or diet.
Children: The safety and effectiveness of using Lantus (Insulin-glargine-long-acting) have not been established for children under 6 years of age.
Seniors: The signs and symptoms of hypoglycemia may be more difficult to recognize in seniors.
Online pharmacies delivering to:
Unit 6 - 6375 Dixie Rd, Mississauga
ON, L5T 2E7
Pocketpills is licensed by Ontario College of PharmacistsAccreditation #: 307234
Pharmacy Manager: Jasneet Dulai
Other locations
© 2018-2024 Pocketpills Pharmacy
By using this website, you accept our Terms of Service and Privacy Policy.
